301 related articles for article (PubMed ID: 16223479)
1. Antidepressants and REM sleep in Wistar-Kyoto and Sprague-Dawley rats.
Ivarsson M; Paterson LM; Hutson PH
Eur J Pharmacol; 2005 Oct; 522(1-3):63-71. PubMed ID: 16223479
[TBL] [Abstract][Full Text] [Related]
2. Ketamine supresses REM sleep and markedly increases EEG gamma oscillations in the Wistar Kyoto rat model of treatment-resistant depression.
Kantor S; Lanigan M; Giggins L; Lione L; Magomedova L; de Lannoy I; Upton N; Duxon M
Behav Brain Res; 2023 Jul; 449():114473. PubMed ID: 37146722
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of the effects of caffeine on sleep in the rat: a potential model of sleep disruption.
Paterson LM; Wilson SJ; Nutt DJ; Hutson PH; Ivarsson M
J Psychopharmacol; 2009 Jul; 23(5):475-86. PubMed ID: 19395429
[TBL] [Abstract][Full Text] [Related]
4. Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorder.
Bonaventure P; Dugovic C; Kramer M; De Boer P; Singh J; Wilson S; Bertelsen K; Di J; Shelton J; Aluisio L; Dvorak L; Fraser I; Lord B; Nepomuceno D; Ahnaou A; Drinkenburg W; Chai W; Dvorak C; Sands S; Carruthers N; Lovenberg TW
J Pharmacol Exp Ther; 2012 Aug; 342(2):429-40. PubMed ID: 22570363
[TBL] [Abstract][Full Text] [Related]
5. R278995/CRA0450, a corticotropin-releasing factor (CRF(1)) receptor antagonist modulates REM sleep measures in rats: Implication for therapeutic indication.
Ahnaou A; Steckler T; Heylen A; Kennis L; Nakazato A; Chaki S; Drinkenburg WH
Eur J Pharmacol; 2012 Apr; 680(1-3):63-8. PubMed ID: 22314225
[TBL] [Abstract][Full Text] [Related]
6. Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents.
Bonaventure P; Kelly L; Aluisio L; Shelton J; Lord B; Galici R; Miller K; Atack J; Lovenberg TW; Dugovic C
J Pharmacol Exp Ther; 2007 May; 321(2):690-8. PubMed ID: 17314195
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide-Y Y2-receptor agonist, PYY3-36 promotes non-rapid eye movement sleep in rat.
Akanmu MA; Ukponmwan OE; Katayama Y; Honda K
Neurosci Res; 2006 Mar; 54(3):165-70. PubMed ID: 16378653
[TBL] [Abstract][Full Text] [Related]
8. The effect of time of day on apnoea index in the sleeping rat.
Stephenson R; Horner RL
Respir Physiol Neurobiol; 2006 Dec; 154(3):351-5. PubMed ID: 16554190
[TBL] [Abstract][Full Text] [Related]
9. Nicotine and fluoxetine induce arousing effects on sleep-wake cycle in antidepressive doses: a possible mechanism of antidepressant-like effects of nicotine.
Vázquez-Palacios G; Hernández-González M; Guevara Pérez MA; Bonilla-Jaime H
Pharmacol Biochem Behav; 2010 Feb; 94(4):503-9. PubMed ID: 19931302
[TBL] [Abstract][Full Text] [Related]
10. Effects of paradoxical sleep deprivation on genital reflexes in five rat strains.
Andersen ML; Antunes IB; Tufik S
Horm Behav; 2006 Feb; 49(2):173-80. PubMed ID: 16005458
[TBL] [Abstract][Full Text] [Related]
11. Circadian rhythms and sleep have additive effects on respiration in the rat.
Stephenson R; Liao KS; Hamrahi H; Horner RL
J Physiol; 2001 Oct; 536(Pt 1):225-35. PubMed ID: 11579171
[TBL] [Abstract][Full Text] [Related]
12. Acute administration of fluoxetine normalizes rapid eye movement sleep abnormality, but not depressive behaviors in olfactory bulbectomized rats.
Wang YQ; Tu ZC; Xu XY; Li R; Qu WM; Urade Y; Huang ZL
J Neurochem; 2012 Jan; 120(2):314-24. PubMed ID: 22035172
[TBL] [Abstract][Full Text] [Related]
13. Depression, sleep, and antidepressants.
Thase ME
J Clin Psychiatry; 1998; 59 Suppl 4():55-65. PubMed ID: 9554322
[TBL] [Abstract][Full Text] [Related]
14. Behavior-dependent modulation of hippocampal EEG activity by the selective norepinephrine reuptake inhibitor reboxetine in rats.
Kocsis B; Li S; Hajos M
Hippocampus; 2007; 17(8):627-33. PubMed ID: 17492692
[TBL] [Abstract][Full Text] [Related]
15. Tetrodotoxin inactivation of pontine regions: influence on sleep-wake states.
Sanford LD; Yang L; Tang X; Ross RJ; Morrison AR
Brain Res; 2005 May; 1044(1):42-50. PubMed ID: 15862788
[TBL] [Abstract][Full Text] [Related]
16. Changes in extracellular glutamate levels in rat orbitofrontal cortex during sleep and wakefulness.
Lopez-Rodriguez F; Medina-Ceja L; Wilson CL; Jhung D; Morales-Villagran A
Arch Med Res; 2007 Jan; 38(1):52-5. PubMed ID: 17174723
[TBL] [Abstract][Full Text] [Related]
17. Chronic mild stress affects sucrose intake and sleep in rats.
Grønli J; Murison R; Bjorvatn B; Sørensen E; Portas CM; Ursin R
Behav Brain Res; 2004 Apr; 150(1-2):139-47. PubMed ID: 15033287
[TBL] [Abstract][Full Text] [Related]
18. Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism.
Leiser SC; Iglesias-Bregna D; Westrich L; Pehrson AL; Sanchez C
J Psychopharmacol; 2015 Oct; 29(10):1092-105. PubMed ID: 26174134
[TBL] [Abstract][Full Text] [Related]
19. Social partnering significantly reduced rapid eye movement sleep fragmentation in fear-conditioned, stress-sensitive Wistar-Kyoto rats.
DaSilva JK; Husain E; Lei Y; Mann GL; Tejani-Butt S; Morrison AR
Neuroscience; 2011 Dec; 199():193-204. PubMed ID: 22015926
[TBL] [Abstract][Full Text] [Related]
20. Gadolinium chloride pretreatment prevents cafeteria diet-induced sleep in rats.
Hansen MK; Krueger JM
Sleep; 1999 Sep; 22(6):707-15. PubMed ID: 10505816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
